Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

HIV drug resistance is a multifactorial phenomenon and constitutes a major concern as it results in therapy failure. The aim of this study was to assess the impact of an amino acid insertion identified at position 33 of the protease gene, derived from samples from three patients under lopinavir therapy, on viral fitness and protease inhibitor (PI) resistance. Successive samples were available from one of the patients for genotypic and phenotypic testing in order to investigate the role of this insertion. The patient had been pretreated with various antiretroviral drugs and showed poor virological response from the point of the acquisition of the mutation onward. The insertion was acquired in the context of a number of other PI mutations and was stable following acquisition. Phenotypic testing revealed reduced susceptibility to various PIs and a reduction of the replicative capacity (RC) of the virus. In the presence of the insertion alone, a decrease of the RC was observed, which seemed to be compensated by the presence of other mutations. The L33ins might have a potential role in PI resistance pathways but further investigation in a larger number of clinical samples is required in order to elucidate this resistance mechanism.

Original publication

DOI

10.1089/AID.2010.0275

Type

Journal article

Journal

AIDS Res Hum Retroviruses

Publication Date

11/2011

Volume

27

Pages

1223 - 1229

Keywords

Amino Acid Sequence, Anti-HIV Agents, Base Sequence, Drug Resistance, Viral, HEK293 Cells, HIV Infections, HIV Protease, HIV Protease Inhibitors, HIV-1, Humans, Lopinavir, Microbial Sensitivity Tests, Molecular Sequence Data, Mutagenesis, Insertional, Sequence Analysis, DNA, Virus Replication